指南与共识重症综合管理与镇静镇痛

人工气道患者沟通干预研究核心结局集:国际德尔菲共识研究(Comm-COS)

A Core Outcome Set for Research Evaluating Interventions to Enable Communication in Patients With an Artificial Airway: An International Delphi Consensus Study (Comm-COS).
指南 / 共识 · Crit Care Med · 2024-06-20
一句话结论Comm-COS 国际共识确立7项核心结局,用于未来人工气道危重成人沟通干预试验的结局统一报告。

危重成人人工气道患者存在严重沟通障碍,但沟通干预研究结局不一,难以解释有效性。本研究通过系统评价、患者/家属访谈、两轮改良德尔菲(第一轮134人投票,第二轮106人投票)及虚拟共识会议,制定国际沟通核心结局集(Comm-COS)。最终Comm-COS包含7项结局:与沟通能力相关的情绪和健康变化、沟通辅助工具使用的身体影响、达到功能性沟通的时间、表达医疗需求的能力、对话主体性、建立沟通连接以发展维持关系的能力、沟通干预的可接受性。这是首个针对危重成人沟通的核心结局集,局限性在于需为这些结局选择测量工具。

要点

  • Comm-COS最终纳入7项核心结局,覆盖情绪健康、身体影响、时间、医疗需求表达、对话主体性、关系建立和可接受性。
  • 德尔菲第一轮32项结局、134人投票(患者/家属15人11%、临床医生91人68%、研究者28人21%)。
  • 第二轮新增9项结局,106人(81%)投票。
  • 系统评价识别59项结局,质性访谈新增3项独特结局,指导委员会补充2项。
  • 局限性:操作化需选择与这些结局匹配的测量工具。

适用人群与场景

  • 需要人工气道的危重成人患者。
  • 利益相关者包括:3年内有亲身经历的患者和家属成员、具有危重症工作经验临床医生、该领域发表论文的研究者。

研究设计与关键结果

  • 研究设计:系统评价、患者/家属访谈、两轮改良德尔菲、虚拟共识会议及最终投票。
  • 系统评价识别59项结局,质性访谈新增3项独特结局,指导委员会补充2项。
  • 德尔菲第一轮呈现32项结局,134人投票:患者/家属15人(11%)、临床医生91人(68%)、研究者28人(21%)。
  • 第二轮新增9项结局,106人(81%)投票。
  • 最终Comm-COS包含7项结局:1)与沟通能力相关的情绪和健康变化;2)沟通辅助工具使用的身体影响;3)达到功能性沟通的时间;4)表达医疗需求(舒适/照护/安全/决策)的能力;5)对话主体性;6)建立沟通连接以发展维持关系的能力;7)沟通干预的可接受性。

证据类型、等级与局限

  • 证据类型:国际德尔菲共识研究。
  • 局限:操作化局限性包括需为这些结局选择测量工具。

对床旁实践的改变

  • 作者认为,未来试验采用Comm-COS有助于建立有效干预,以改善沟通无能这一高发且负面的体验。

指南或共识出处

  • Comm-COS(Crit Care Med)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Critically ill adults requiring artificial airways experience profound communication deficits. Studies of interventions supporting communication report disparate outcomes, creating subsequent challenges in the interpretation of their effectiveness. Therefore, we aimed to develop international consensus for a communication core outcome set (Comm-COS) for future trials of communication interventions in this population.

DESIGN: 1) Systematic review, 2) patient/family interviews, 3) two-round modified Delphi, and 4) virtual consensus meetings with a final voting round. A multidisciplinary expert steering committee oversaw all stages.

SETTING: Interviews and consensus meetings were conducted via videoconferencing. Digital methods were used for Delphi and final Comm-COS voting.

SUBJECTS: Three stakeholder groups: 1) patient and family members with lived experience within 3 years, 2) clinicians with experience working in critical care, and 3) researchers publishing in the field.

MEASUREMENTS AND MAIN RESULTS: We identified 59 outcomes via our systematic review, 3 unique outcomes from qualitative interviews, and 2 outcomes from our steering committee. Following item reduction, 32 outcomes were presented in Delphi round 1; 134 participants voted; 15 patient/family (11%), 91 clinicians (68%), and 28 researchers (21%). Nine additional outcomes were generated and added to round 2; 106 (81%) participants voted. Following completion of the consensus processes, the Comm-COS includes seven outcomes: 1) changes in emotions and wellbeing associated with ability to communicate, 2) physical impact of communication aid use, 3) time to functional communication, 4) ability to communicate healthcare needs (comfort/care/safety/decisions), 5) conversation agency, 6) ability to establish a communication connection to develop and maintain relationships, and 7) acceptability of the communication intervention.

CONCLUSIONS: This is the first COS to specifically focus on communication for critically ill adults. Limitations for operationalization include selection of measures to use with these outcomes. Identification of suitable measures and adoption of the Comm-COS in future trials will help establish effective interventions to ameliorate the highly prevalent and negative experience of communicative incapacity.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Freeman-Sanderson A, Brodsky MB, Dale C, et al. A Core Outcome Set for Research Evaluating Interventions to Enable Communication in Patients With an Artificial Airway: An International Delphi Consensus Study (Comm-COS). Crit Care Med. 2024. PMID: 38899947. doi:10.1097/CCM.0000000000006347

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。